U.S. Professional Services Stock News

NasdaqGS:LOT
NasdaqGS:LOTAuto

Does Lotus Technology's (LOT) Auditor Switch Reveal a Deeper Shift in Governance and Transparency Priorities?

Lotus Technology Inc. has replaced its independent auditor, dismissing KPMG Huazhen LLP and appointing Grant Thornton Zhitong Certified Public Accountants LLP to audit its consolidated financial statements for the fiscal year ended December 31, 2025. This shift in audit oversight is important for investors because it can influence confidence in the company’s financial reporting quality and governance practices. We’ll now explore how this auditor change might influence Lotus Technology’s...
NYSE:UNF
NYSE:UNFCommercial Services

UniFirst (UNF) Margin Stability At 6.1% Tests Bulls Earnings Acceleration Narrative

Q1 2026 earnings snapshot UniFirst (UNF) opened its new fiscal year with Q1 2026 results anchored by prior quarter revenue of US$614.4 million and basic EPS of US$2.23, with trailing twelve month EPS at US$8.01 on US$2.4 billion of revenue and net income of US$148.3 million. Over recent quarters the company has seen revenue move from US$603.3 million in Q3 2024 to US$604.9 million in Q1 2025 and then to US$610.8 million and US$614.4 million in Q3 and Q4 2025, while quarterly EPS has tracked...
NasdaqGS:CHYM
NasdaqGS:CHYMDiversified Financial

Assessing Chime Financial (CHYM) Valuation After Recent Share Price Momentum

Understanding Chime Financial’s Recent Share Performance Chime Financial (CHYM) has recently drawn investor attention after a period of relatively strong share price performance, with the stock showing positive returns over the past week, month and past 3 months. See our latest analysis for Chime Financial. At a share price of $27.23, Chime Financial’s short term momentum has been firm, with a 30 day share price return of 13.84% and a 90 day share price return of 27.99%, while the year to...
NasdaqGS:APOG
NasdaqGS:APOGBuilding

Apogee Enterprises (APOG) Margin Compression To 3.2% Challenges Bullish Earnings Narratives

Apogee Enterprises Q3 2026 Earnings Snapshot Apogee Enterprises (APOG) has just turned in another data point in a volatile stretch, with recent quarterly revenue sitting at about US$358.2 million and basic EPS of roughly US$1.10, against a trailing twelve month picture that shows total revenue of about US$1.39 billion and EPS of roughly US$2.07. Over the last few reported quarters, the company has seen revenue move from about US$331.5 million and EPS of roughly US$1.42 in early 2025 to the...
NYSE:AIR
NYSE:AIRAerospace & Defense

AAR Corp (AIR) Margin Recovery In Q2 2026 Reinforces Bullish Profitability Narratives

AAR Corp. (AIR) has reported results for Q2 2026, with revenue of US$795.3 million and basic EPS of US$0.92, alongside trailing twelve month EPS of US$2.59 and net income of US$94.1 million. The company’s revenue has increased from US$686.1 million in Q2 2025 to US$795.3 million in Q2 2026, while quarterly EPS has moved from a loss of US$0.87 to a profit of US$0.92. This represents a very large year-over-year earnings improvement that feeds into forecasts calling for about 34.7% annual...
NasdaqGS:DRS
NasdaqGS:DRSAerospace & Defense

Is Leonardo DRS (DRS) Starting To Look Fully Priced After Its Strong Three Year Run

If you are wondering whether Leonardo DRS is still reasonably priced after its recent run, this article walks through what the current numbers may imply about value. The stock most recently closed at US$37.20, with returns of 9.1% over 7 days, 9.7% over 30 days, 7.0% year to date and 12.9% over the past year, as well as a very large 3 year return of 194.0%. Recent coverage has focused on Leonardo DRS as a US defense and electronics business, with investors watching how its positioning in...
NasdaqGS:PSMT
NasdaqGS:PSMTConsumer Retailing

What PriceSmart (PSMT)'s Strong Q1 Results and New Club Expansion Plan Means For Shareholders

PriceSmart, Inc. has released its fiscal first-quarter 2026 results, reporting net income of US$40.2 million, earnings of US$1.29 per share, and revenue of US$1.38 billion from its 56 warehouse clubs across 12 countries and one U.S. territory. The company also highlighted 8.0% comparable net merchandise sales growth and outlined plans to expand to 60 clubs, including a tenth location in Costa Rica, underscoring continued emphasis on club rollouts in existing markets. Next, we’ll examine how...
NYSE:CHH
NYSE:CHHHospitality

Is Choice Hotels (CHH) Pricing Leave Much Upside After Recent Share Price Rebound

Wondering if Choice Hotels International is priced attractively right now, or if the current share price is already baking in most of the upside? The stock last closed at US$104.68, with returns of 8.7% over 7 days and 22.1% over 30 days, while the 1 year return is a 24.6% decline and the 3 year and 5 year returns are 5.5% and 1.5% respectively. Recent attention on Choice Hotels International has centered on how the business is positioned within the wider consumer services sector and how...
NasdaqCM:BYRN
NasdaqCM:BYRNAerospace & Defense

Is Byrna Technologies (BYRN) Pricing In Too Much Pessimism After A 35% One-Year Decline?

If you are wondering whether Byrna Technologies at around US$17.50 is a bargain or already pricing in a lot of optimism, you are in the right place. The stock has been through a mixed patch, with a 1.4% gain over the last week, an 11.0% decline over the past month, a 4.7% gain year to date, a 35.3% decline over the past year, and a 94.4% gain over three years that leaves the five year return at 25.0%. These swings have kept Byrna Technologies on the radar of investors watching how sentiment...
NasdaqGM:VCEL
NasdaqGM:VCELBiotechs

Is It Time To Reconsider Vericel (VCEL) After Recent Share Price Volatility?

If you are wondering whether Vericel's current share price lines up with its underlying worth, this article walks through the numbers in a clear, structured way. Vericel recently closed at US$39.34, with returns of 9.2% over 7 days, 5.5% over 30 days, 10.5% year to date, a 33.9% decline over 1 year, 42.4% over 3 years and 6.6% over 5 years. Taken together, these figures provide a mix of shorter term momentum and longer term context. That performance sits against a backdrop of ongoing...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Top Insider-Owned Growth Companies To Watch In January 2026

As the U.S. stock market experiences mixed movements with the Dow Jones and S&P 500 reaching fresh all-time highs, investors are keeping a close eye on geopolitical developments and economic indicators such as employment data. In this environment, growth companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those who know the business best and may offer resilience amid market fluctuations.
NasdaqGM:TKNO
NasdaqGM:TKNOLife Sciences

3 Promising Penny Stocks With Market Caps Up To $300M

Major stock indexes in the United States have recently shown mixed performance, with the Dow Jones Industrial Average and S&P 500 setting fresh all-time highs. Amid these fluctuating market conditions, investors are increasingly exploring diverse opportunities to maximize potential returns. Penny stocks, though a term from earlier market days, continue to represent intriguing investment prospects by offering access to smaller or newer companies at lower price points. By identifying those with...
NYSE:HIPO
NYSE:HIPOInsurance

Discovering Hidden Opportunities in US Stocks

As the Dow Jones and S&P 500 reach new all-time highs, the U.S. stock market continues to capture investors' attention amidst mixed economic signals, including a weakening labor market and geopolitical developments. In this dynamic environment, identifying promising small-cap stocks can offer valuable opportunities for growth, particularly when these companies demonstrate resilience and potential in sectors poised for expansion.
NasdaqCM:DCTH
NasdaqCM:DCTHMedical Equipment

A Look At Delcath Systems (DCTH) Valuation After New Phase 3 FOCUS Subgroup Data On HEPZATO KIT

Delcath Systems (DCTH) is back in focus after publishing detailed subgroup analyses from its phase 3 FOCUS study on HEPZATO KIT in unresectable metastatic uveal melanoma, helping refine how clinicians view efficacy and safety across different patient groups. See our latest analysis for Delcath Systems. The publication arrives after a mixed stretch for Delcath Systems, with a 30 day share price return of 6.85% and a 90 day share price return decline of 5.86%. The 3 year total shareholder...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Is Tempus AI (TEM) Stock Price Reflecting Its Rapid 1‑Year Surge?

If you are asking whether Tempus AI is priced attractively or already baking in a lot of optimism, the rest of this article is built to help you assess that question clearly. Tempus AI shares last closed at US$69.54, with returns of 15.2% over the past 7 days, an 11.5% gain year to date and a 78.9% return over the last year. The 30 day return sits at a 9.3% decline. Recent attention on Tempus AI has centered on its position in applying AI tools to healthcare data and its potential role in...